[ARNA] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[ARNA] Arena Pharmaceuticals, Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -157.17%
YoY- -2.34%
Quarter Report
ARNA's Result
ARNA's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 262 801,057 1,755 6,624 9,847 12,256 6,814 -41.87%
PBT -100,207 730,467 -31,182 -22,533 -21,524 -24,256 -25,218 25.82%
Tax 5,669 110,333 1,259 -461 -650 -816 67 109.38%
NP -100,207 620,134 -31,963 -22,053 -21,548 -24,295 -25,255 25.79%
Tax Rate - -15.10% - - - - - -
Total Cost 100,469 180,923 33,718 28,677 31,395 36,551 32,069 20.94%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -38,246.95 77.41 -1,821.25 -332.93 -218.83 -198.23 -370.63 116.42%
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.00 12.53 -0.80 -0.90 -0.89 -1.03 -1.15 9.65%
EPS Diluted -2.00 12.10 -0.80 -0.90 -0.89 -1.03 -1.15 9.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.